This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Innoscience counters Infineon's patent-infringement accusations as 'baseless' competitive tactics

By MLex Staff ( August 5, 2024, 07:25 GMT | Insight) -- Innoscience, a Chinese gallium-nitride technology pioneer, has rebuffed what it described as “baseless” accusations of patent infringement made by its German rival Infineon Technologies, branding them as “strategic attempts” aimed at unfairly tarnishing Innoscience's market reputation. The Chinese company’s remarks, made in a statement released on the weekend, came after Infineon’s recent move to petition the US International Trade Commission for a Section 337 investigation and to expand claims in an ongoing lawsuit against Innoscience at a US court.Innoscience, a Chinese gallium-nitride technology pioneer, has rebuffed what it described as “baseless” accusations of patent infringement made by its German rival Infineon Technologies, branding them as “strategic attempts” aimed at unfairly tarnishing Innoscience's market reputation. The Chinese company’s remarks, made in a statement released on the weekend, came after Infineon’s recent move to petition the US International Trade Commission, or ITC, for a Section 337 investigation and to expand claims in an ongoing lawsuit against Innoscience at a US court....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections